Authors
O Decombe, L Lenfant, B Faurie, P Mozer, E Chartier-Kastler
Published in
Current urology reports. Volume 27. Issue 1. Nov 03, 2026. Epub Nov 03, 2026.
Abstract
Stress urinary incontinence (SUI) secondary to intrinsic sphincter deficiency (ISD) remains a challenging condition in women with persistent or recurrent incontinence despite conservative or surgical treatment. Artificial urinary sphincter (AUS) implantation represents an established salvage option. This review summarizes recent evidence on clinical outcomes, evolving surgical approaches, quality-of-life outcomes, and emerging device technologies in women undergoing AUS implantation.
A PubMed search of studies published between 2019 and 2025, conducted according to PRISMA 2020 guidelines, identified 30 eligible studies. Reported continence rates ranged from 59% to 84%, while revision and explantation rates ranged from 6% to 69% and 2% to 34%, respectively. Contemporary patient populations increasingly comprise complex revision cases, particularly following synthetic sling removal. Minimally invasive and robotic approaches have emerged as promising alternatives, improving surgical precision and reducing perioperative morbidity, although comparative evidence remains limited and their impact on long term device survival is not established. Beyond continence, AUS implantation may improve quality of life. Early findings also suggest possible benefits in female sexual function, although further studies are needed to confirm these observations. Emerging electromechanical and pump-free systems may offer further improvements in device usability and complication profiles, but their clinical benefits remain to be established.
Over the last five years, the literature on female urinary sphincter devices has been dominated by retrospective studies, resulting in a generally low level of evidence. Most publications focus on AUS in women and consist of single-center retrospective case series. The European Association of Urology-led VENUS registry was established to address this limitation by collecting real-world data on AUS implantation and outcomes in women with stress urinary incontinence due to intrinsic sphincter deficiency. Patient recruitment has recently accelerated, with more than 13 centers currently enrolling and additional centers in the initiation process [1]. Emerging prospective studies on AUS and adjustable continence therapy (ACT) balloons may further strengthen the evidence base in the near future. AUS remains a valuable salvage therapy for severe female SUI related to ISD. Despite substantial revision and explantation rates, advances in surgical techniques and device design hold promise for improving patient experience and functional outcomes. Further prospective studies with long-term follow-up are needed to clarify the comparative effectiveness of surgical approaches, assess the impact of emerging technologies on device durability, and better characterize the effects of AUS implantation on female sexual function.
PMID:
42975789
Bibliographic data and abstract were imported from PubMed on 04 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0